WESTPAC BANKING CORP – Vertex Pharmaceuticals Incorporated Transaction History
WESTPAC BANKING CORP portfolio value:
$10.48M
portfolio value
WESTPAC BANKING CORP quarter portfolio value change:
+2.75%
quarter
Vertex Pharmaceuticals Incorporated 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -9.61% | -3.85K shares | -804.19K | $289.54 | 36.21K |
| Q2 2022 | share | Decrease | -3.61% | -1.50K shares | 442.26K | $281.79 | 40.06K |
| Q1 2022 | share | Increase | +59.89% | 15.57K shares | 5.13M | $260.97 | 41.57K |
| Q4 2021 | share | Decrease | -0.28% | -73 shares | 980.21K | $222.45 | 26K |
| Q3 2021 | share | Decrease | -62.01% | -42.56K shares | -9.11M | $181.39 | 26.07K |
| Q2 2021 | share | Increase | +7.09% | 4.54K shares | 65.87K | $201.63 | 68.63K |
| Q1 2021 | share | Increase | +0.56% | 359 shares | -1.29M | $214.89 | 64.09K |
| Q4 2020 | share | Increase | +74.16% | 27.14K shares | 5.10M | $236.34 | 63.73K |
| Q3 2020 | share | Increase | +9.86% | 3.28K shares | 287.95K | $272.12 | 36.59K |
| Q2 2020 | share | Decrease | -15.04% | -5.89K shares | 340.60K | $290.31 | 33.31K |
| Q1 2020 | share | Increase | +60.00% | 14.70K shares | 3.96M | $237.95 | 39.21K |
| Q4 2019 | share | Increase | +9.45% | 2.11K shares | 1.57M | $218.95 | 24.50K |
| Q3 2019 | share | 0.00% | 0 shares | -312.59K | $169.42 | 22.39K | |
| Q2 2019 | share | Decrease | -67.94% | -47.46K shares | -8.74M | $183.38 | 22.39K |
| Q1 2019 | share | Decrease | -35.12% | -37.81K shares | -4.99M | $183.95 | 69.85K |
| Q4 2018 | share | Decrease | -5.49% | -6.25K shares | -4.11M | $165.71 | 107.67K |
| Q3 2018 | share | Decrease | -14.06% | -18.63K shares | -572.43K | $192.74 | 113.92K |
| Q2 2018 | share | Decrease | -0.43% | -577 shares | 831.27K | $169.96 | 132.56K |
| Q1 2018 | share | Increase | +14.63% | 16.99K shares | 4.29M | $162.98 | 133.14K |
| Q4 2017 | share | Increase | +52.73% | 40.1K shares | 5.84M | $149.86 | 116.15K |
| Q3 2017 | share | Increase | +125.20% | 42.28K shares | 7.21M | $152.04 | 76.05K |
| Q2 2017 | share | Decrease | -34.59% | -17.85K shares | -1.29M | $128.87 | 33.77K |
| Q1 2017 | share | Decrease | -2.94% | -1.56K shares | 1.31M | $109.35 | 51.62K |
| Q4 2016 | share | Increase | +5.98% | 3K shares | -47.39K | $73.67 | 53.18K |
| Q3 2016 | share | Increase | +6.33% | 2.98K shares | 316.58K | $87.21 | 50.18K |
| Q2 2016 | share | Increase | +52.19% | 16.18K shares | 1.59M | $86.02 | 47.20K |
| Q1 2016 | share | Increase | +192.58% | 20.41K shares | 1.13M | $79.49 | 31.01K |